Dapsone/niacinamide/tretinoin topical Interactions
There are 116 drugs known to interact with dapsone/niacinamide/tretinoin topical, along with 2 disease interactions. Of the total drug interactions, 14 are major, 41 are moderate, and 61 are minor.
Medications known to interact with dapsone/niacinamide/tretinoin topical
Note: Showing generic names only.
- aminoglutethimide
- aminolevulinic acid
- aminolevulinic acid topical
- amobarbital
- amyl nitrite
- apalutamide
- armodafinil
- benoxinate ophthalmic
- benzocaine topical
- benzoyl peroxide topical
- bexarotene
- bosentan
- bupivacaine
- bupivacaine liposome
- butabarbital
- butalbital
- carbamazepine
- cenobamate
- chloroprocaine
- chloroprocaine ophthalmic
- chloroquine
- clascoterone topical
- cocaine nasal
- cocaine topical
- levobupivacaine
- lidocaine
- lidocaine ophthalmic
- lidocaine otic
- lidocaine topical
- lonapegsomatropin
- lorlatinib
- mavacamten
- mephobarbital
- mepivacaine
- methotrexate
- methoxsalen
- methyl aminolevulinate topical
- mitotane
- modafinil
- pentobarbital
- pexidartinib
- phenobarbital
- phenylbutazone
- phenytoin
- porfimer
- pralatrexate
- pramoxine topical
- prednisolone
- prednisone
- prilocaine
- primaquine
- primidone
- procaine
- procaine penicillin
- proguanil
- proparacaine ophthalmic
- pyrimethamine
- salicylic acid topical
- secobarbital
- silver nitrate topical
- silver sulfadiazine topical
- sodium nitrite
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- st. john's wort
- sulfadiazine
- sulfadoxine
- sulfamethizole
- sulfamethoxazole
- sulfinpyrazone
- sulfisoxazole
- sulfur topical
- suzetrigine
- tafenoquine
- tazemetostat
- tetracaine
- tetracaine ophthalmic
- tetracaine topical
- trimethoprim
- trimetrexate
- troglitazone
Dapsone/niacinamide/tretinoin topical disease interactions
There are 2 disease interactions with dapsone / niacinamide / tretinoin topical which include:
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.